The global anticancer drugs market would grow at a compound annual growth rate (CAGR) of more than 7% during the forecast period from 2021-2030.
Anticancer drugs are medicines that are prescribed for the treatment of cancers. The most common cancer drugs are Revlimid, Procarbazine, Carmustine, Altretamine, Temozolomide, and Mechlorethamine.
The global anticancer drugs market is growing at a significant rate, owing to the increasing pervasiveness of several types of cancer. Furthermore, researches on the development of effective anticancer drugs would propel the growth of the global anticancer drugs market during the forecast period.
Request To Download Free Sample of This Strategic Report @https://reportocean.com/industry-verticals/sample-request?report_id=BWCC627
The growing number of cancer patients and their treatment procedures are boosting the growth of the global anticancer drug market. According to the International Agency for Research on Cancer (IARC), around 17 million people were diagnosed with cancer in 2018, out of which 9.5 million cancer deaths were registered globally. Moreover, the numbers are expected to hike by 2040. Thus, the demand for anticancer drugs is forecast to surge during the forecast time frame.
Cancer treatment essentially requires effective drugs to control the disease. Thus, the pharmaceutical and biotechnology companies continuously invest in R & D activities to develop advanced drugs. Various research institutes are engaged in the development of hybrid anticancer drugs. The drugs would be effective in destroying cancer cells, which, in turn, cure the disease more efficiently. Thus, the advancements in anticancer drugs would prompt the growth of the global market.
Anticancer drugs have long-lasting side effects on patients. The cancer patients have to go through chemotherapy, which causes fatigue, edema (swelling), diarrhea, nausea, vomiting, etc. Anticancer drugs can cause breathlessness and increase the risk of infection. Thus, such side effects can slow down the growth of the global anticancer drugs market.
COVID-19 Impact Analysis
The sudden onset of COVID-19 created chaos in the entire world. Healthcare bodies had to postpone the diagnosis and treatment of many other diseases. However, the pandemic had a positive impact on the growth of the global anticancer drug market. The risk of infection prevented many patients from visiting hospitals. This, in turn, soared the demand for anticancer drugs as patients were more reliant on drugs those days.
Regional Analysis
Geographically, North America holds the maximum share in the global anticancer drug market, owing to the growing number of cancer cases in the region. Around 1.9 million people in North America are suffering from breast cancer, lung cancer, and prostate cancer. Such factors are anticipated to soar the growth of the global anticancer drug market.
Competitors In The Market
- F. Hoffmann-La Roche Ltd.(Europe)
- Pfizer Inc.(United States)
- Novartis AG (Europe)
- Merck & Co. Inc.(United States)
- Bristol-Myers Squibb Company (United States)
- AstraZeneca PLC (United Kingdom)
- Astellas Pharma Inc. (Japan)
- AbbVie Inc. (United States)
- Amgen (United States)
- Takeda Oncology Drugs Ltd. (United States)
- GlaxoSmithKline (United Kingdom)
- Sanofi (Europe)
- Celgene Corporation (United States)
- Boehringer Ingelheim GmbH (Germany)
- Teva Pharmaceuticals (Asia)
- Eli Lilly and Company(United States)
- Millennium Pharmaceuticals(United States)
- Other prominent players.
Market Segmentation
By Drug Class
- Cytotoxic Drugs
- Alkylating Agents
- Antimetabolites
- Others
- Targeted Drugs
- Monoclonal Antibodies
- Others
- Hormonal Drugs
By Therapy
- Chemotherapy
- Targeted Therapy
- Immunotherapy
By Indication
- Lung Cancer
- Breast Cancer
- Stomach Cancer
- Colorectal Cancer
- Prostate Cancer
- Others
By Dosage Form
- Solid
- Tablets
- Capsules
- Liquid
- Injectable
- Prefilled Syringes
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online
- Others
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- Western Europe
- The UK
- Germany
- France
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Poland
- Russia
- Rest of Eastern Europe
- Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- UAE
- Saudi Arabia
- South Africa
- Rest of MEA
- South America
- Brazil
- Argentina
Table of Content
Chapter 1: Global Anticancer Drugs Industry Overview
Chapter 3: Market Dynamics
Chapter 4: Top Company Profiles
Chapter 5: Global Anticancer Drugs market Competition, by Players
Chapter 6: Global Market Size by Regions
Chapter 7: Global Market Segment by Application
Chapter 8: Global Anticancer Drugs Industry Segment by Type
Chapter 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Chapter 10: Strategies and key policies by Distributors/Suppliers/Traders
Chapter 11: Key Marketing Strategy Analysis, by Market Vendors
Chapter 12: Market Effect Factors Analysis
Chapter 13: Global Anticancer Drugs market Size Forecast (2023-2032).
Continue….
Reasons to Buy This Report
(A) The research provides valuable insights for top administration, policymakers, professionals, product advancements, sales managers, and stakeholders in the market. It helps them make informed decisions and strategize effectively.
(B) The report offers comprehensive analysis of Anticancer Drugs market revenues on a global, regional, and country level, projecting trends until 2032. This data allows companies to assess their market share, identify growth opportunities, and explore new markets.
(C) The research includes segmentation of the Anticancer Drugs market based on types, applications, technologies, and end-uses. This segmentation enables leaders to plan their products and allocate resources based on the expected growth rates of each segment.
(D) Analysis of the Anticancer Drugs market benefits investors by providing insights into market scope, position, key drivers, challenges, restraints, expansion opportunities, and potential threats. This information helps them make informed investment decisions.
(E) The report offers a detailed analysis of competitors, their key strategies, and market positioning. This knowledge allows businesses to better understand the competition and plan their own strategies accordingly.
(F) The study helps evaluate Anticancer Drugs business predictions by region, key countries, and top companies, providing valuable information for investment planning and decision-making.
About Report Ocean:
Report Ocean is a renowned provider of market research reports, offering high-quality insights to clients in various industries. Their goal is to assist clients in achieving their top line and bottom line objectives, thereby enhancing their market share in today’s competitive environment. As a trusted source for innovative market research reports, Report Ocean serves as a comprehensive solution for individuals, organizations, and industries seeking valuable market intelligence.